Miaoling Tang

1.1k total citations · 1 hit paper
28 papers, 719 citations indexed

About

Miaoling Tang is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Miaoling Tang has authored 28 papers receiving a total of 719 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 12 papers in Cancer Research and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Miaoling Tang's work include RNA modifications and cancer (6 papers), Epigenetics and DNA Methylation (5 papers) and Cancer, Lipids, and Metabolism (5 papers). Miaoling Tang is often cited by papers focused on RNA modifications and cancer (6 papers), Epigenetics and DNA Methylation (5 papers) and Cancer, Lipids, and Metabolism (5 papers). Miaoling Tang collaborates with scholars based in China, Australia and United States. Miaoling Tang's co-authors include Libing Song, Shuxia Zhang, Jun Li, Ziwen Li, Geyan Wu, Yameng Hu, Ruyuan Yu, Meisongzhu Yang, Xinyi Liao and Jinrong Zhu and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and Molecular Cell.

In The Last Decade

Miaoling Tang

27 papers receiving 713 citations

Hit Papers

LPCAT1-mediated membrane phospholipid remodelling promote... 2024 2026 2025 2024 20 40 60

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Miaoling Tang China 15 512 305 139 132 100 28 719
Weihao Lin China 15 412 0.8× 206 0.7× 160 1.2× 140 1.1× 65 0.7× 33 650
Lu Zang China 12 716 1.4× 448 1.5× 216 1.6× 111 0.8× 81 0.8× 26 923
Dongdong Tong China 20 805 1.6× 574 1.9× 112 0.8× 93 0.7× 73 0.7× 44 1000
Hyo-Sung Jeon South Korea 15 658 1.3× 260 0.9× 196 1.4× 163 1.2× 61 0.6× 25 834
Jun Ji China 12 370 0.7× 269 0.9× 160 1.2× 133 1.0× 109 1.1× 19 613
Hongchao Zhao China 17 546 1.1× 391 1.3× 165 1.2× 71 0.5× 77 0.8× 38 794
Yosuke Endo‐Sakamoto Japan 17 456 0.9× 203 0.7× 173 1.2× 72 0.5× 80 0.8× 37 634
Huizhi Sun China 16 478 0.9× 313 1.0× 188 1.4× 72 0.5× 76 0.8× 23 641
Xianhui Ruan China 16 647 1.3× 332 1.1× 262 1.9× 138 1.0× 101 1.0× 63 982
Shilei Tang China 13 596 1.2× 365 1.2× 102 0.7× 148 1.1× 108 1.1× 15 810

Countries citing papers authored by Miaoling Tang

Since Specialization
Citations

This map shows the geographic impact of Miaoling Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miaoling Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miaoling Tang more than expected).

Fields of papers citing papers by Miaoling Tang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miaoling Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miaoling Tang. The network helps show where Miaoling Tang may publish in the future.

Co-authorship network of co-authors of Miaoling Tang

This figure shows the co-authorship network connecting the top 25 collaborators of Miaoling Tang. A scholar is included among the top collaborators of Miaoling Tang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miaoling Tang. Miaoling Tang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huo, Hongliang, Wentao Li, Juan Yin, et al.. (2025). Development and validation of a recurrence risk prediction model for elderly schizophrenia patients. BMC Psychiatry. 25(1). 73–73. 2 indexed citations
3.
Hu, Yameng, Xingui Wu, Shuxia Zhang, et al.. (2025). Targeting PRDX6-dependent localization and function of GPX4 enhances ferroptosis-mediated tumor suppression. Molecular Cell. 85(24). 4602–4620.e9.
4.
Tang, Miaoling, Shuxia Zhang, Meisongzhu Yang, et al.. (2024). Infiltrative Vessel Co-optive Growth Pattern Induced by IQGAP3 Overexpression Promotes Microvascular Invasion in Hepatocellular Carcinoma. Clinical Cancer Research. 30(10). 2206–2224. 7 indexed citations
5.
Hu, Yameng, Haiqing Zheng, Xincheng Li, et al.. (2024). LPCAT1-mediated membrane phospholipid remodelling promotes ferroptosis evasion and tumour growth. Nature Cell Biology. 26(5). 811–824. 60 indexed citations breakdown →
6.
Zhang, Shuxia, Xincheng Li, Xingui Wu, et al.. (2024). Dynamic structural remodeling of LINC01956 enhances temozolomide resistance in MGMT -methylated glioblastoma. Science Translational Medicine. 16(767). eado1573–eado1573. 5 indexed citations
7.
Li, Yuxiao, et al.. (2024). Different clinicopathological features between young and older patients with pulmonary adenocarcinoma and ground-glass opacity. Scientific Reports. 14(1). 15679–15679. 1 indexed citations
8.
Zhang, Yifan, Guangjian Liu, Qianwen Zeng, et al.. (2024). CCL19-producing fibroblasts promote tertiary lymphoid structure formation enhancing anti-tumor IgG response in colorectal cancer liver metastasis. Cancer Cell. 42(8). 1370–1385.e9. 51 indexed citations
9.
Li, Ziwen, Xinyi Liao, Yameng Hu, et al.. (2023). SLC27A4-mediated selective uptake of mono-unsaturated fatty acids promotes ferroptosis defense in hepatocellular carcinoma. Free Radical Biology and Medicine. 201. 41–54. 26 indexed citations
10.
Liao, Xinyi, Haiqing Zheng, Shuxia Zhang, et al.. (2023). Downregulation of BASP1 Promotes Temozolomide Resistance in Gliomas via Epigenetic Activation of the FBXO32/NF-κB/MGMT Axis. Molecular Cancer Research. 21(7). 648–663. 6 indexed citations
11.
Xu, Yingru, Xincheng Li, Shuxia Zhang, et al.. (2023). CircMMP2(6,7) Cooperates with β-Catenin and PRMT5 to Disrupt Bone Homeostasis and Promote Breast Cancer Bone Metastasis. Cancer Research. 84(2). 328–343. 12 indexed citations
12.
Zhang, Xin, Liangliang Ren, Junhua Wu, et al.. (2022). ARHGEF37 overexpression promotes extravasation and metastasis of hepatocellular carcinoma via directly activating Cdc42. Journal of Experimental & Clinical Cancer Research. 41(1). 230–230. 16 indexed citations
13.
Tang, Miaoling, Meisongzhu Yang, Geyan Wu, et al.. (2021). Epigenetic Induction of Mitochondrial Fission Is Required for Maintenance of Liver Cancer–Initiating Cells. Cancer Research. 81(14). 3835–3848. 52 indexed citations
14.
Wu, Geyan, Peng Hu, Miaoling Tang, et al.. (2021). ZNF711 down-regulation promotes CISPLATIN resistance in epithelial ovarian cancer via interacting with JHDM2A and suppressing SLC31A1 expression. EBioMedicine. 71. 103558–103558. 51 indexed citations
15.
Tang, Miaoling, et al.. (2020). Mesenchymal stem cells-originated exosomal microRNA-152 impairs proliferation, invasion and migration of thyroid carcinoma cells by interacting with DPP4. Journal of Endocrinological Investigation. 43(12). 1787–1796. 14 indexed citations
16.
Zhu, Jinrong, Geyan Wu, Libing Song, et al.. (2019). NKX2-8 deletion-induced reprogramming of fatty acid metabolism confers chemoresistance in epithelial ovarian cancer. EBioMedicine. 43. 238–252. 47 indexed citations
17.
Cao, Lixue, Geyan Wu, Jinrong Zhu, et al.. (2019). Genotoxic stress-triggered β-catenin/JDP2/PRMT5 complex facilitates reestablishing glutathione homeostasis. Nature Communications. 10(1). 3761–3761. 41 indexed citations
18.
Wu, Geyan, Lixue Cao, Jinrong Zhu, et al.. (2018). Loss of RBMS3 Confers Platinum Resistance in Epithelial Ovarian Cancer via Activation of miR-126-5p/β-catenin/CBP signaling. Clinical Cancer Research. 25(3). 1022–1035. 45 indexed citations
19.
Zhu, Jinrong, Geyan Wu, Zunfu Ke, et al.. (2018). Targeting TRIM3 deletion-induced tumor-associated lymphangiogenesis prohibits lymphatic metastasis in esophageal squamous cell carcinoma. Oncogene. 38(15). 2736–2749. 20 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026